Thomas Woiwode is Director of CRISPR Therapeutics AG. Currently has a direct ownership of 5,629 shares of CRSP, which is worth approximately $261,129. The most recent transaction as insider was on May 08, 2018, when has been sold 1,653 shares (Common Shares) at a price of $51.45 per share, resulting in proceeds of $85,047. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.63K
0% 3M change
0% 12M change
Total Value Held $261,129

Thomas Woiwode Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2018
SELL
Open market or private sale
$85,047 $51.45 p/Share
1,653 Reduced 22.7%
5,629 Common Shares
Apr 20 2018
BUY
Other acquisition or disposition
-
2,323 Added 24.19%
7,282 Common Shares
Dec 22 2017
SELL
Open market or private sale
$62,067 $20.29 p/Share
3,059 Reduced 38.15%
4,959 Common Shares
Nov 27 2017
SELL
Open market or private sale
$4,048 $20.24 p/Share
200 Reduced 2.43%
8,018 Common Shares
Nov 24 2017
SELL
Open market or private sale
$34,357 $20.21 p/Share
1,700 Reduced 17.14%
8,218 Common Shares
Sep 05 2017
BUY
Other acquisition or disposition
-
9,918 Added 50.0%
9,918 Common Stock

Also insider at

ALGS
Aligos Therapeutics, Inc. Healthcare
ADVM
Adverum Biotechnologies, Inc. Healthcare
GRTS
Gritstone bio, Inc. Healthcare
PASG
Passage BIO, Inc. Healthcare
TPST
Tempest Therapeutics, Inc. Healthcare
TW

Thomas Woiwode

Director
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP